Form 8-K - Current report:
SEC Accession No. 0001404644-25-000004
Filing Date
2025-01-13
Accepted
2025-01-13 07:30:18
Documents
64
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20250113.htm   iXBRL 8-K 26967
2 EX-99.1 a202501_ngnecorporatepre.htm EX-99.1 61153
6 a202501_ngnecorporatepre001.jpg GRAPHIC 103953
7 a202501_ngnecorporatepre002.jpg GRAPHIC 276048
8 a202501_ngnecorporatepre003.jpg GRAPHIC 97916
9 a202501_ngnecorporatepre004.jpg GRAPHIC 70672
10 a202501_ngnecorporatepre005.jpg GRAPHIC 130424
11 a202501_ngnecorporatepre006.jpg GRAPHIC 37699
12 a202501_ngnecorporatepre007.jpg GRAPHIC 115335
13 a202501_ngnecorporatepre008.jpg GRAPHIC 112625
14 a202501_ngnecorporatepre009.jpg GRAPHIC 86516
15 a202501_ngnecorporatepre010.jpg GRAPHIC 83362
16 a202501_ngnecorporatepre011.jpg GRAPHIC 82234
17 a202501_ngnecorporatepre012.jpg GRAPHIC 76230
18 a202501_ngnecorporatepre013.jpg GRAPHIC 98610
19 a202501_ngnecorporatepre014.jpg GRAPHIC 126229
20 a202501_ngnecorporatepre015.jpg GRAPHIC 96868
21 a202501_ngnecorporatepre016.jpg GRAPHIC 88082
22 a202501_ngnecorporatepre017.jpg GRAPHIC 98077
23 a202501_ngnecorporatepre018.jpg GRAPHIC 99049
24 a202501_ngnecorporatepre019.jpg GRAPHIC 91753
25 a202501_ngnecorporatepre020.jpg GRAPHIC 102241
26 a202501_ngnecorporatepre021.jpg GRAPHIC 151913
27 a202501_ngnecorporatepre022.jpg GRAPHIC 112978
28 a202501_ngnecorporatepre023.jpg GRAPHIC 129655
29 a202501_ngnecorporatepre024.jpg GRAPHIC 126005
30 a202501_ngnecorporatepre025.jpg GRAPHIC 99258
31 a202501_ngnecorporatepre026.jpg GRAPHIC 103865
32 a202501_ngnecorporatepre027.jpg GRAPHIC 114740
33 a202501_ngnecorporatepre028.jpg GRAPHIC 80049
34 a202501_ngnecorporatepre029.jpg GRAPHIC 131251
35 a202501_ngnecorporatepre030.jpg GRAPHIC 30071
36 a202501_ngnecorporatepre031.jpg GRAPHIC 83237
37 a202501_ngnecorporatepre032.jpg GRAPHIC 134978
38 a202501_ngnecorporatepre033.jpg GRAPHIC 124540
39 a202501_ngnecorporatepre034.jpg GRAPHIC 113063
40 a202501_ngnecorporatepre035.jpg GRAPHIC 118032
41 a202501_ngnecorporatepre036.jpg GRAPHIC 106284
42 a202501_ngnecorporatepre037.jpg GRAPHIC 96002
43 a202501_ngnecorporatepre038.jpg GRAPHIC 69315
44 a202501_ngnecorporatepre039.jpg GRAPHIC 95871
45 a202501_ngnecorporatepre040.jpg GRAPHIC 69286
46 a202501_ngnecorporatepre041.jpg GRAPHIC 119885
47 a202501_ngnecorporatepre042.jpg GRAPHIC 37193
48 a202501_ngnecorporatepre043.jpg GRAPHIC 66516
49 a202501_ngnecorporatepre044.jpg GRAPHIC 30285
50 a202501_ngnecorporatepre045.jpg GRAPHIC 137554
51 a202501_ngnecorporatepre046.jpg GRAPHIC 129056
52 a202501_ngnecorporatepre047.jpg GRAPHIC 119692
53 a202501_ngnecorporatepre048.jpg GRAPHIC 87652
54 a202501_ngnecorporatepre049.jpg GRAPHIC 89503
55 a202501_ngnecorporatepre050.jpg GRAPHIC 82829
  Complete submission text file 0001404644-25-000004.txt   7216716

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250113.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250113_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250113_pre.xml EX-101.PRE 13050
66 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250113_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 25524806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)